I am a
Home I AM A Search Login

Papers of the Week

2020 Jun 17

Expert Opin Investig Drugs

Novel agents for the treatment of polycythemia vera: an insight into preclinical research and early phase clinical trials.


Current treatment for polycythemia vera (PV) is limited and primarily targets thrombosis risk. Agents targeting distinct mechanisms of action within myeloproliferation are undergoing clinical evaluation to optimize efficacy, improve tolerance and augment long term disease complications.